help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, L.
Right arrow Articles by Sherins, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, L.
Right arrow Articles by Sherins, R. J.

Journal of Clinical Endocrinology & Metabolism, Vol 64, 651-656, Copyright © 1987 by Endocrine Society


ARTICLES

Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism

L Liu, GR Merriam and RJ Sherins

Sex steroid administration can increase the GH response to provocative stimuli, but the relationship of sex steroids to spontaneous GH secretion is still controversial. We sought to characterize the effect of sex steroids on the plasma GH concentration by examining the 24-h pattern of episodic GH secretion in nine previously untreated adult men with isolated hypogonadotropic hypogonadism before and during long term testosterone, gonadotropin, or pulsatile GnRH treatment. After chronic sex steroid exposure, the mean 24-h plasma GH level, mean GH pulse amplitude, and mean area under the curve of pulses were significantly increased compared to pretreatment values [3.2 +/- 1.8 ( +/- SD) vs. 1.8 +/- 1.2 ng/mL (P less than 0.01); 11.4 +/- 7.2 vs. 5.5 +/- 4.4 ng/mL (P less than 0.05); and 720 +/- 547 vs. 316 +/- 371 ng/mL X 20 min (P less than 0.05), respectively], while mean 24-h pre- and posttreatment GH pulse frequencies were indistinguishable (5.7 +/- 2.1 posttreatment vs. 5.0 +/- 3.2 pretreatment; P = NS). The mean posttreatment plasma somatomedin-C level also rose significantly during treatment (1.89 +/- 0.65 vs. 1.28 +/- 0.48 U/mL; P less than 0.01). We conclude that the increase in the mean plasma GH level during chronic sex steroid exposure is due mainly to augmentation of GH pulse amplitude, and that sex steroids probably increase spontaneous GH secretion.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. Paulo, M. Cosma, C. Soares-Welch, J. N. Bailey, K. L. Mielke, J. M. Miles, C. Y. Bowers, and J. D. Veldhuis
Gonadal Status and Body Mass Index Jointly Determine Growth Hormone (GH)-Releasing Hormone/GH-Releasing Peptide Synergy in Healthy Men
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 944 - 950.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Muniyappa, J. D. Sorkin, J. D. Veldhuis, S. M. Harman, T. Munzer, S. Bhasin, and M. R. Blackman
Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E769 - E775.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. J. Christiansen, S. Fisker, C. H. Gravholt, P. Bennett, B. Svenstrup, M. Andersen, U. Feldt-Rasmussen, J. S. Christiansen, and J. O. L. Jorgensen
Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I
Eur. J. Endocrinol., May 1, 2005; 152(5): 719 - 726.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. P A Rooman, L. O. De Beeck, M. Martin, J. van Doorn, S. Mohan, and M. V L Du Caju
Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature
Eur. J. Endocrinol., April 1, 2005; 152(4): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Endocr. Rev., February 1, 2005; 26(1): 114 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. J. Orrego, E. Dimaraki, K. Symons, and A. L. Barkan
Physiological Testosterone Replenishment in Healthy Elderly Men Does Not Normalize Pituitary Growth Hormone Output: Evidence against the Connection between Senile Hypogonadism and Somatopause
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3255 - 3260.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Schurgin, S. Dolan, A. Perlstein, M. P. Sullivan, N. Aliabadi, and S. Grinspoon
Effects of Testosterone Administration on Growth Hormone Pulse Dynamics in Human Immunodeficiency Virus-Infected Women
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3290 - 3297.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. Dolan, S. Wilkie, N. Aliabadi, M. P. Sullivan, N. Basgoz, B. Davis, and S. Grinspoon
Effects of Testosterone Administration in Human Immunodeficiency Virus-Infected Women With Low Weight: A Randomized Placebo-Controlled Study
Arch Intern Med, April 26, 2004; 164(8): 897 - 904.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Nakamura, M. Mizuno, H. Katakami, A. C. Gore, and E. Terasawa
Aging-Related Changes in in Vivo Release of Growth Hormone-Releasing Hormone and Somatostatin from the Stalk-Median Eminence in Female Rhesus Monkeys (Macaca mulatta)
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 827 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Woller, G. Everson-Binotto, E. Nichols, A. Acheson, K. L. Keen, C. Y. Bowers, and E. Terasawa
Aging-Related Changes in Release of Growth Hormone and Luteinizing Hormone in Female Rhesus Monkeys
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5160 - 5167.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B.-A. Bengtsson, R. Abs, H. Bennmarker, J. P. Monson, U. Feldt-Rasmussen, E. Hernberg-Ståhl, B. Westberg, P. Wilton, and C. Wüster
The Effects of Treatment and the Individual Responsiveness to Growth Hormone (GH) Replacement Therapy in 665 GH-Deficient Adults
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3929 - 3935.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Grinspoon, C. Corcoran, T. Stanley, L. Katznelson, and A. Klibanski
Effects of Androgen Administration on the Growth Hormone-Insulin-Like Growth Factor I Axis in Men with Acquired Immunodeficiency Syndrome Wasting
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4251 - 4256.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. A. Fryburg, A. Weltman, L. A. Jahn, J. Y. Weltman, E. Samojlik, R. L. Hintz, and J. D. Veldhuis
Short-Term Modulation of the Androgen Milieu Alters Pulsatile, But Not Exercise- or Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Healthy Men: Impact of Gonadal Steroid and GH Secretory Changes on Metabolic Outcomes
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3710 - 3719.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. P. Cemeroglu, A. L. Barkan, G. B. Kletter, I. Z. Beitins, and C. M. Foster
Changes in Serum Immunoreactive and Bioactive Growth Hormone Concentrations in Boys with Advancing Puberty and in Response to a 20-Hour Estradiol Infusion
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2166 - 2171.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Giustina, T. Scalvini, C. Tassi, P. Desenzani, C. Poiesi, W. B. Wehrenberg, A. D. Rogol, and J. D. Veldhuis
Maturation of the Regulation of Growth Hormone Secretion in Young Males with Hypogonadotropic Hypogonadism Pharmacologically Exposed to Progressive Increments in Serum Testosterone
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1210 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Johannsson, P. Marin, L. Lonn, M. Ottosson, K. Stenlof, P. Bjorntorp, L. Sjostrom, and B.-A. Bengtsson
Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 727 - 734.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Loche, A. Colao, M. Cappa, J. Bellone, G. Aimaretti, G. Farello, A. Faedda, G. Lombardi, R. Deghenghi, and E. Ghigo
The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 861 - 864.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society